• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
GBIO

GBIO

Generation Bio Co.

NASDAQHealthcareBiotechnologyUS

USD5.34

+0.00 (+0.00%)

Company Profile

CEO

Yalonda Howze

IPO Date

2020-06-12

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$5.34

Prev. Close

$5.34

Day Low

$5.34

Day High

$5.34

52W Low

$3.00

52W High

$7.52

Market Cap

$0.04B

Volume

0.55M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

30.0%

Avg Negative

1.5%

Avg Neutral

68.6%

News Feed

Generation Bio Announces Plan to Scale Next-Generation Rapid Enzymatic Manufacturing Process Across Portfolio and Provides Pipeline Update

GlobeNewsWire·7/14/2021·↑ positive

Generation Bio to Present at William Blair Biotech Focus Conference

GlobeNewsWire·7/8/2021·↑ positive

Generation Bio to Present at the JMP Securities Life Sciences Conference

GlobeNewsWire·6/9/2021·↑ positive

Generation Bio to Present at the Jefferies Virtual Healthcare Conference

GlobeNewsWire·5/27/2021·↑ positive

Generation Bio Presents Preclinical Data Demonstrating Broad Potential of Gene Therapy Platform at ASGCT and Reports First Quarter Financial Results

GlobeNewsWire·5/12/2021·↑ positive

Generation Bio to Present at American Society of Gene & Cell Therapy 2021 Virtual Annual Meeting

GlobeNewsWire·4/27/2021·↑ positive

Generation Bio to Present at 20th Annual Needham Virtual Healthcare Conference

GlobeNewsWire·4/8/2021·↑ positive

Why Earnings Season Could Be Great for Generation Bio (GBIO)

Zacks Investment Research·3/1/2021·↑ positive

Generation Bio: Pioneering A New Class Of Gene Therapy

Seeking Alpha·2/24/2021·↑ positive

Generation Bio Appoints Ron Cooper to Its Board of Directors

GlobeNewsWire·2/18/2021·↓ negative